The Wall Street Journal: Johnson & Johnson Says Discounts Cut the Prices for Its Drugs, Though Revenue Rose

The Wall Street Journal: Johnson & Johnson Says Discounts Cut the Prices for Its Drugs, Though Revenue Rose

Health plans and drug-benefit managers are “more aggressive” restricting access to expensive drugs